ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,357,651 | -39.1% | 6,452,550 | -24.1% | 0.00% | -33.3% |
| Q2 2023 | $31,779,924 | -59.0% | 8,497,306 | -63.3% | 0.00% | -25.0% |
| Q1 2023 | $77,541,640 | +37.3% | 23,146,758 | +97.2% | 0.00% | -33.3% |
| Q4 2022 | $56,456,937 | -20.6% | 11,737,409 | -6.0% | 0.01% | -14.3% |
| Q3 2022 | $71,061,000 | -20.2% | 12,488,746 | -0.4% | 0.01% | -22.2% |
| Q2 2022 | $89,030,000 | -2.0% | 12,539,475 | -0.3% | 0.01% | +28.6% |
| Q1 2022 | $90,826,000 | -18.5% | 12,579,791 | +0.9% | 0.01% | -12.5% |
| Q4 2021 | $111,441,000 | -74.4% | 12,465,409 | +0.4% | 0.01% | -77.1% |
| Q3 2021 | $435,324,000 | +63.3% | 12,416,533 | +0.0% | 0.04% | +66.7% |
| Q2 2021 | $266,579,000 | -59.9% | 12,410,530 | +15.4% | 0.02% | -63.2% |
| Q1 2021 | $664,357,000 | +146.6% | 10,758,795 | +66.9% | 0.06% | +137.5% |
| Q4 2020 | $269,384,000 | – | 6,447,692 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |